Although the ALT+GGT combination improved the accuracy of NAFLD screening, it required complex formula calculations and evaluations, which increased the workload for primary care physicians and reduced time efficiency. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.